Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Regulus Therapeutics Inc (RGLS)
Regulus Therapeutics Inc (RGLS) Financials

RGLS Regulus Therapeutics Inc

1.60

-0.02 (-1.23%)

Pre Market

Last Updated: 13:58:35

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-67.705	-80.579	-92.133	-53.114	-39.48	-52.439	-49.185	-77.549
Return on Equity (%)	-90.852	-157.529	-331.783	-262.58	-68.33	-68.675	-64.189	-110.272
Return on Invested Capital (%)	-81.721	-126.742	-328.517	-242.326	-61.552	-65.189	-60.926	-114.112
Operating Margin (%)	-6755.276	-96359.722	-64311.111	-240.925	-139.137	N/A	N/A	N/A
Net Profit Margin (%)	-6853.936	-99868.056	-67651.389	-272.131	-157.206	N/A	N/A	N/A
Book Value Per Share	1.04	0.331	-0.721	0.939	0.384	0.376	1.973	0.83
Earnings Per Share	-1.546	-0.692	-5.524	-0.885	-0.233	-0.191	-1.682	-1.179
Cash Per Share	0.282	0.13	1.58	1.623	0.461	0.414	1.439	0.933
Working Capital Per Share	1.392	0.328	-0.834	0.895	0.373	0.411	1.925	0.772
Operating Profit Per Share	0.023	0.001	0.008	0.325	0.148	N/A	N/A	N/A
EBIT Per Share	-1.546	-0.694	-5.517	-0.884	-0.233	-0.19	-1.682	-1.178
EBITDA Per Share	-1.546	-0.694	-5.517	-0.884	-0.233	-0.19	-1.682	-1.178
Free Cash Flow Per Share	-1.571	-0.713	-5.778	-0.917	-0.24	-0.192	-1.668	-1.163

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	52.93M	103.96M	8.82M	21.02M	67.43M	145.97M	16.84M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	16.84M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	106.11M
Price to Earnings Ratio	-3.53
Price to Sales Ratio	0
Price to Cash Ratio	4.46
Price to Book Ratio	5.01
Dividend Yield	-

Share Statistics

Shares Outstanding	65.5M
Average Volume (1 week)	336.97k
Average Volume (1 Month)	255.04k
52 Week Change	18.52%
52 Week High	3.78
52 Week Low	1.08

More Ratios Coming Soon!

Regulus Therapeutics

Value Liquidity

JAPK25 - Maio 2025

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions